Loading insider details...
Beta
Latest Form 4 (Oct 7, 2026): Sale of 30,000 AMLX shares, $830.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 30,000 | $830.9K |
| Jun 8, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 24,372 | n/a |
| Jan 14, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift | 17,780 | n/a |
| Jun 9, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 25,000 | n/a |
| Jan 28, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift | 27,910 | n/a |
| Sep 5, 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase | 100,000 | $219.8K |
| Jun 7, 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 25,000 | n/a |
| Jan 29, 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift | 9,100 | n/a |
| Jan 18, 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift | 94,350 | n/a |
| Jun 12, 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 16,985 | n/a |